BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 23419824)

  • 1. The burden of liver disease in Europe: a review of available epidemiological data.
    Blachier M; Leleu H; Peck-Radosavljevic M; Valla DC; Roudot-Thoraval F
    J Hepatol; 2013 Mar; 58(3):593-608. PubMed ID: 23419824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of viral hepatitis in Africa.
    Bojuwoye BJ
    West Afr J Med; 1997; 16(4):198-203. PubMed ID: 9473953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimation on disease burden related to hepatitis B virus infection in Shandong province of China].
    Qi WT; Sun JD; Xu AQ; Zhang L; Li RP; Ma JX; Guo XL; Fan QY; Yang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):679-83. PubMed ID: 19957589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver disease in Europe.
    Burroughs A; McNamara D
    Aliment Pharmacol Ther; 2003 Nov; 18 Suppl 3():54-9. PubMed ID: 14531742
    [No Abstract]   [Full Text] [Related]  

  • 5. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of chronic hepatic disease in Portugal. Apropos of a review carried out in a hepatology unit].
    Valente AI; Almeida A; Gouveia A; Serejo F; Ramalho F; Baptista A; Saragoça A; Moura MC
    Acta Med Port; 1996; 9(7-9):197-202. PubMed ID: 9005696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global impact of hepatic fibrosis and end-stage liver disease.
    Lim YS; Kim WR
    Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of liver diseases in the GDR, 1979-1989].
    Truckenbrodt J; Schmidt H; Bohndorf HJ
    Gastroenterol J; 1991; 51(3-4):129-31. PubMed ID: 1811656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.
    Trombetta M; Spiazzi G; Zoppini G; Muggeo M
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():24-7. PubMed ID: 16225467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem.
    García-Fulgueiras A; García-Pina R; Morant C; de Larrea-Baz NF; Alvarez E
    J Viral Hepat; 2011 Oct; 18(10):e453-60. PubMed ID: 21914063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiological pattern of chronic liver diseases in a community undergoing voluntary screening for hepatitis B and C.
    Zani C; Pasquale L; Bressanelli M; Puoti M; Paris B; Coccaglio R; Lascioli I; Pieriacci G; Donato F
    Dig Liver Dis; 2011 Aug; 43(8):653-8. PubMed ID: 21530428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study.
    Goldacre MJ; Wotton CJ; Yeates D; Seagroatt V; Collier J
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):384-92. PubMed ID: 18403939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
    Hickman IJ; Russell AJ; Prins JB; Macdonald GA
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e10-2. PubMed ID: 18187226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L; Lemoine M
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y; Yamagishi Y; Ishii H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
    Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
    J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A cross-sectional study on liver diseases in the rural residents in southern Guangxi, China].
    Huang TR; Yu JH; Li JL; Zhang ZQ; Deng W; Zhang CY; Zhao SF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():123-6. PubMed ID: 17767876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current views on liver diseases in Ethiopia.
    Tsega E
    Ethiop Med J; 1977 Apr; 15(2):75-82. PubMed ID: 201462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic liver disease--an increasing problem: a study of hospital admission and mortality rates in England, 1979-2005, with particular reference to alcoholic liver disease.
    Thomson SJ; Westlake S; Rahman TM; Cowan ML; Majeed A; Maxwell JD; Kang JY
    Alcohol Alcohol; 2008; 43(4):416-22. PubMed ID: 18385412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contributions of viral hepatitis and alcohol to liver-related deaths in opioid-dependent people.
    Larney S; Randall D; Gibson A; Degenhardt L
    Drug Alcohol Depend; 2013 Aug; 131(3):252-7. PubMed ID: 23237980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.